News
CARTILAGO ANNOUNCES CLINICAL STUDY RESULTS CONFIRMING THE EFFICACY OF REGEN LONGEVITY IN REDUCING PERIOCULAR WRINKLES
November 11, 2022
Rome, Italy 11th November, 2022 – Cartilago, a clinical stage regenerative medicine company founded by Cube Labs, announced today the results from an analysis of
Cartilago Announces Clinical Study for Regen Longevity Anti-Ageing Skin Treatment
August 10, 2021
ROME, Italy Cartilago, a clinical stage regenerative medicine company, has announced a clinical study for Regen Longevity, a regenerative peptide candidate being developed to increase
Cartilago Receives Seed Capital From CDP’s Southern Italy Business Fund
July 15, 2020
Cartilago has received seed investment from CDP Venture Capital – National Innovation Fund of Italy’s “Italy Venture II – Southern Italy Business Fund.” The fund